Pfizer (PFE) Current Taxes (2009 - 2026)
Pfizer (PFE) reported Current Taxes of $3.1 billion for Q1 2026, up 0.81% year-over-year from $3.1 billion in Q1 2025, and up 0.87% on a QoQ basis from $3.1 billion in Q4 2025.
Pfizer (PFE) has 18 years of Current Taxes data on file, last reported at $3.1 billion in Q1 2026.
- Quarterly Current Taxes rose 0.81% year-over-year to $3.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 billion (up 0.81% YoY) and the FY2025 annual result came in at $3.1 billion, up 6.63% from the prior year.
- Current Taxes improved to $3.1 billion in Q1 2026 per PFE's latest filing, from $3.1 billion in the prior quarter.
- Across five years, Current Taxes topped out at $3.8 billion in Q3 2025 and bottomed at $1.6 billion in Q4 2022.
- The 5-year median for Current Taxes is $3.1 billion (2022), against an average of $2.9 billion.
- The widest annual swing landed in 2022, when Current Taxes surged 126.77%; it then tumbled 38.2% in 2023.
- Tracing PFE's Current Taxes over 5 years: stood at $1.6 billion in 2022, then surged by 48.02% to $2.3 billion in 2023, then grew by 23.88% to $2.9 billion in 2024, then climbed by 6.63% to $3.1 billion in 2025, then grew by 0.87% to $3.1 billion in 2026.
- Per Business Quant, the three latest PFE Current Taxes figures stand at $3.1 billion (Q1 2026), $3.1 billion (Q4 2025), and $3.8 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 1.09 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | - |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 3.95 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | - |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 3.13 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | - |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 662.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 3.13 Bn |
| Dec 31, 2025 | 3.10 Bn |
| Sep 28, 2025 | 3.80 Bn |
| Jun 29, 2025 | 3.68 Bn |
| Mar 30, 2025 | 3.11 Bn |
| Dec 31, 2024 | 2.91 Bn |
| Sep 29, 2024 | 2.88 Bn |
| Jun 30, 2024 | 2.88 Bn |
| Mar 31, 2024 | 3.19 Bn |
| Dec 31, 2023 | 2.35 Bn |
| Oct 1, 2023 | 1.90 Bn |
| Jul 2, 2023 | 2.93 Bn |
| Apr 2, 2023 | 1.97 Bn |
| Dec 31, 2022 | 1.59 Bn |
| Oct 2, 2022 | 3.07 Bn |
| Jul 3, 2022 | 3.35 Bn |
| Apr 3, 2022 | 3.18 Bn |
| Dec 31, 2021 | 1.27 Bn |
| Oct 3, 2021 | 4.50 Bn |
| Jul 4, 2021 | 1.74 Bn |
| Apr 4, 2021 | 1.40 Bn |
| Dec 31, 2020 | 1.05 Bn |
| Sep 27, 2020 | 1.43 Bn |
| Jun 28, 2020 | 1.45 Bn |
| Mar 29, 2020 | 1.15 Bn |
| Dec 31, 2019 | 980.00 Mn |
| Sep 29, 2019 | 1.89 Bn |
| Jun 30, 2019 | 1.54 Bn |
| Mar 31, 2019 | 1.85 Bn |
| Dec 31, 2018 | 1.27 Bn |
| Sep 30, 2018 | 2.78 Bn |
| Jul 1, 2018 | 2.48 Bn |
| Apr 1, 2018 | 1.61 Bn |
| Dec 31, 2017 | 477.00 Mn |
| Oct 1, 2017 | 1.00 Bn |
| Jul 2, 2017 | 552.00 Mn |
| Apr 2, 2017 | 790.00 Mn |
| Dec 31, 2016 | 437.00 Mn |
| Oct 2, 2016 | 1.16 Bn |
| Jul 3, 2016 | 647.00 Mn |
| Apr 3, 2016 | 920.00 Mn |
| Dec 31, 2015 | 418.00 Mn |
| Sep 27, 2015 | 1.18 Bn |
| Jun 28, 2015 | 1.06 Bn |
| Mar 29, 2015 | 944.00 Mn |
| Dec 31, 2014 | 531.00 Mn |
| Sep 28, 2014 | 892.00 Mn |
| Jun 29, 2014 | 760.00 Mn |
| Mar 30, 2014 | 851.00 Mn |
| Dec 31, 2013 | 678.00 Mn |
| Sep 29, 2013 | 802.00 Mn |
| Jun 30, 2013 | 904.00 Mn |
| Mar 31, 2013 | 1.16 Bn |
| Dec 31, 2012 | 979.00 Mn |
| Sep 30, 2012 | 1.79 Bn |
| Jul 1, 2012 | 2.10 Bn |
| Apr 1, 2012 | 1.93 Bn |
| Dec 31, 2011 | 1.01 Bn |
| Oct 2, 2011 | 2.22 Bn |
| Jul 3, 2011 | 1.85 Bn |
| Apr 3, 2011 | 1.96 Bn |
| Dec 31, 2010 | 951.00 Mn |
| Oct 3, 2010 | 1.62 Bn |
| Jul 4, 2010 | 727.00 Mn |
| Apr 4, 2010 | 765.00 Mn |
| Dec 31, 2009 | 10.11 Bn |
| Sep 27, 2009 | 485.00 Mn |
| Jun 28, 2009 | 607.00 Mn |